Molecular basis of macrolide-lincosamide-streptogramin (MLS) resistance in Finegoldia magna clinical isolates.
Anaerobe
; 64: 102220, 2020 Aug.
Article
em En
| MEDLINE
| ID: mdl-32531434
ABSTRACT
Of 69 clinical isolates of Finegoldia magna tested, 36% presented high-level MICs of erythromycin (>256 µg/ml), harboring erm(A) (n = 20) or erm(B) (n=5). Of nine isolates exhibiting an inducible resistance phenotype to macrolides-lincosamides-streptogramins B, four (44%) were susceptible with a potential risk of treatment failure due to emergence of resistant mutants.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Macrolídeos
/
Estreptograminas
/
Farmacorresistência Bacteriana Múltipla
/
Lincosamidas
/
Firmicutes
/
Metiltransferases
Tipo de estudo:
Diagnostic_studies
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Anaerobe
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
França